Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.13M Buy
8,527
+1,271
+18% +$162K 0.08% 113
2024
Q4
$821K Buy
7,256
+946
+15% +$109K 0.06% 124
2024
Q3
$719K Sell
6,310
-17
-0.3% -$1.86K 0.05% 137
2024
Q2
$657K Buy
6,327
+1,682
+36% +$178K 0.05% 137
2024
Q1
$528K Buy
4,645
+780
+20% +$89.4K 0.05% 136
2023
Q4
$425K Sell
3,865
-239
-6% -$23.9K 0.04% 137
2023
Q3
$397K Buy
4,104
+1,018
+33% +$107K 0.04% 135
2023
Q2
$336K Sell
3,086
-20
-0.6% -$2.13K 0.04% 137
2023
Q1
$315K Buy
3,106
+156
+5% +$16.5K 0.04% 142
2022
Q4
$324K Buy
+2,950
New +$305K 0.04% 136
2022
Q1
Sell
-1,670
Closed -$235K 123
2021
Q4
$235K Buy
+1,670
New +$214K 0.03% 123

Other funds holding ABT

Callan Capital's ABT Position: Q1 2025 in Review

Callan Capital increased its Abbott (ABT) stake by 18% in Q1 2025, buying an estimated $162K and bringing the position to 8,527 shares worth $1.13M. The position accounts for 0.08% of the portfolio, ranked #113.

Callan Capital first reported a position in ABT in Q4 2021 and has held it in 11 quarters since. 3,168 funds tracked by Wall St. Rank hold ABT as of Q1 2025.

  • Callan Capital held 8,527 shares of Abbott worth $1.13M as of Q1 2025.
  • Callan Capital bought 1,271 Abbott shares in Q1 2025, an estimated $162K.
  • Abbott made up 0.08% of Callan Capital's portfolio in Q1 2025, its #113 holding.
  • Callan Capital first reported a position in Abbott in Q4 2021 and has held it in 11 quarters since.
  • 3,168 funds tracked by Wall St. Rank held Abbott as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.